We tested a battery of cytokines, including IL-8, TNFα, MIP1, MCP1, IL-4, and IL-17a, in pretreatment (basal) serum samples of melanoma patients who responded to TIL treatment (n = 8) as compared with patients who failed to respond (n = 8). Here, IL17A is linked to melanoma.